Tiziana Life Sciences Ltd (TLSA) Form 6-K — Oct 21, 2026

$TLSAForm 6-KFiled Oct 21, 2026, 7:00 AM ET0001213900-26-111173Original filing

Tiziana Life Sciences (Nasdaq: TLSA) announced that its management and business development team will attend the 10th Joint ACTRIMS-ECTRIMS Meeting (MSToronto2026), held October 21-23, 2026 in Toronto. The company said representatives will discuss its clinical programs, including the INFORM-MS Phase 2a trial of intranasal foralumab in non-active secondary progressive multiple sclerosis, plus ongoing studies in Alzheimer's disease, MSA, and ALS.

Key figures

Conference dates: October 21-23, 2026
Ea program patients dosed: 14

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.